Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Explore how Sp 500 stacks up against the Total Stock Market for retirement investing, focusing on long-term growth, volatility, and portfolio diversification.
28,492 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
SpaceX, Rocket Lab, and AST SpaceMobile retreat as a China rocket milestone and an oil price spike pressure space-sto...
Lucid shares sank as new reports claim the EV maker is weighing drastic options, including a take-private or Chapter ...
Realty Income just announced a $1 billion joint venture with Apollo, expanding its real estate platform and preservin...
A mid-sized fund wrapped up a $9 million exit from a major pawn shop operator after a rally of about 150% over the ye...
The AI wave is accelerating, and savvy investors are looking for blue-chip names with durable AI catalysts. This guid...
VW's 100,000-job layoff plan signals a broader shift in auto manufacturing. As Chinese EVs tighten market share, inve...
Microsoft’s latest earnings show a resilient AI-powered expansion, with a $627 billion backlog and a near $37 billion...
A billionaire activist investor is stepping in with a bold move on Pinterest. This deep dive breaks down what this co...
CrowdStrike is grabbing renewed attention on Wall Street after reporting record ARR growth and its first GAAP profit,...
Imagine an ETF that allocates nearly one-third of its assets to SpaceX. This deep dive explains how that could happen...
MicroStrategy remains tethered to Bitcoin moves, but bullish bets persist as the company expands its digital-asset st...